Navegar por autor "Ramos Cabrer, Pedro"

A novel theranostic agent for the treatment of stroke

2012- Sobrino Moreiras, Tomas; Blanco González, Miguel; Castillo Sánchez, José; Ramos Cabrer, Pedro; Barral Raña, David; [et al.]

Comparacion de la lesion producida en tres modelos animales de isquemia cerebral focal permanente mediante resonancia magnetica.

2011- Castillo Sánchez, José; Brea López, David; Pérez Mato, María; Ramos Cabrer, Pedro; Agulla Freire, Jesús; [et al.]

Evaluation of glutamate role in the effect of temperature on cerebral ischemia. An in vivo magnetic resonance spectroscopic analysis

2012- Campos Pérez, Francisco; Castillo Sánchez, José; Brea López, David; Pérez Mato, María; Ramos Cabrer, Pedro; [et al.]

Glutamate Excitoxicity Is the Key Molecular Mechanism Which Is Influenced by Body Temperature during the Acute Phase of Brain Stroke

2012- Campos Pérez, Francisco; Pérez Mato, María; Agulla Freire, Jesús; Blanco González, Miguel; Barral Raña, David; [et al.]

Growth factors mediate reduction of infarct volume and functional recovery in cerebral ischemia through the increase of circulating mesenchymal stem cells

2012- Sobrino Moreiras, Tomas; Blanco González, Miguel; Rodríguez Yáñez, Manuel; Castillo Sánchez, José; Arias Rivas, Susana; [et al.]

Guía de recomendaciones en la aplicación de modelos animales para el estudio del ictus

2011- Castillo Sánchez, José; Ramos Cabrer, Pedro; Agulla Freire, Jesús

High blood glutamate oxaloacetate transaminase levels are associated with good functional outcome in acute ischemic stroke

2011- Campos Pérez, Francisco; Sobrino Moreiras, Tomas; Ramos Cabrer, Pedro; Castellanos, Mar; Blanco González, Miguel; [et al.]

Human recombinant glutamate oxaloacetate transaminase 1 (GOT1) supplemented with oxaloacetate induces a protective effect after cerebral ischemia

2014- Pérez Mato, María; Ramos Cabrer, Pedro; Sobrino, T.; Blanco González, Miguel; Ruban, A.; [et al.]

Los niveles de expresión de los receptores toll-like 2 y 4 en neutrófilos se asocian con el pronóstico de los pacientes con ictus isquémico.

2011- Sobrino Moreiras, Tomas; Blanco González, Miguel; Castillo Sánchez, José; Brea López, David; Ramos Cabrer, Pedro [et al.]

Molecular profiling of the peri-infarct region dynamics in cerebral ischemia

2012- Rodríguez Yáñez, Manuel; Castillo Sánchez, José; Arias Rivas, Susana; Brea López, David; Pérez Mato, María; [et al.]

MRI Stem Cell Tracking for Therapy in Experimental Cerebral Ischemia

2012- Ramos Cabrer, Pedro

Neuroprotection afforded by antagonists of endothelin-1 receptors in experimental stroke

2012- Sobrino Moreiras, Tomas; Blanco González, Miguel; Castillo Sánchez, José; Ramos Cabrer, Pedro; Barral Raña, David; [et al.]

Neuroprotection by glutamate oxaloacetate transaminase in ischemic stroke: an experimental study.

2011- Campos Pérez, Francisco; Sobrino Moreiras, Tomas; Ramos Cabrer, Pedro; Argibay, Bárbara; Agulla Freire, Jesús; [et al.]

OXALOACETATE INDUCES A POTENTIATION OF THE PROTECTIVE EFFECTS OF GLUTAMATE OXALOACETATE TRANSAMINASE AFTER CEREBRAL ISCHEMIA

2013- Campos Pérez, Francisco; Castillo Sánchez, José; Pérez Mato, María; Ramos Cabrer, Pedro; Andrade Martín, Raul [et al.]

Oxaloacetate: A novel neuroprotective for acute ischemic stroke

2012- Sobrino Moreiras, Tomas; Campos Pérez, Francisco; Castillo Sánchez, José; Ramos Cabrer, Pedro

Pre-stimulation of mesenchymal stem cells with growth factors increase their neurorepair effects in cerebral ischemia

2012- Sobrino Moreiras, Tomas; Castillo Sánchez, José; Brea López, David; Pérez Mato, María; Ramos Cabrer, Pedro; [et al.]

Repositorio digital RUNA

Navegar por autor "Ramos Cabrer, Pedro"

A novel theranostic agent for the treatment of stroke ﻿

Comparacion de la lesion producida en tres modelos animales de isquemia cerebral focal permanente mediante resonancia magnetica. ﻿

Evaluation of glutamate role in the effect of temperature on cerebral ischemia. An in vivo magnetic resonance spectroscopic analysis ﻿

Glutamate Excitoxicity Is the Key Molecular Mechanism Which Is Influenced by Body Temperature during the Acute Phase of Brain Stroke ﻿

Growth factors mediate reduction of infarct volume and functional recovery in cerebral ischemia through the increase of circulating mesenchymal stem cells ﻿

Guía de recomendaciones en la aplicación de modelos animales para el estudio del ictus ﻿

High blood glutamate oxaloacetate transaminase levels are associated with good functional outcome in acute ischemic stroke ﻿

Human recombinant glutamate oxaloacetate transaminase 1 (GOT1) supplemented with oxaloacetate induces a protective effect after cerebral ischemia ﻿

In Vivo Theranostics at the Peri-Infarct Region in Cerebral Ischemia ﻿

Influence of temperature on ischemic brain: Basic and clinical principles ﻿

Interleukin-10 facilitates the selection of patients for systemic thrombolysis ﻿

Liposomes and nanotechnology in drug development: focus on neurological targets ﻿

Los niveles de expresión de los receptores toll-like 2 y 4 en neutrófilos se asocian con el pronóstico de los pacientes con ictus isquémico. ﻿

Molecular profiling of the peri-infarct region dynamics in cerebral ischemia ﻿

MRI Stem Cell Tracking for Therapy in Experimental Cerebral Ischemia ﻿

Neuroprotection afforded by antagonists of endothelin-1 receptors in experimental stroke ﻿

Neuroprotection by glutamate oxaloacetate transaminase in ischemic stroke: an experimental study. ﻿

OXALOACETATE INDUCES A POTENTIATION OF THE PROTECTIVE EFFECTS OF GLUTAMATE OXALOACETATE TRANSAMINASE AFTER CEREBRAL ISCHEMIA ﻿

Oxaloacetate: A novel neuroprotective for acute ischemic stroke ﻿

Pre-stimulation of mesenchymal stem cells with growth factors increase their neurorepair effects in cerebral ischemia ﻿

A novel theranostic agent for the treatment of stroke

Comparacion de la lesion producida en tres modelos animales de isquemia cerebral focal permanente mediante resonancia magnetica.

Evaluation of glutamate role in the effect of temperature on cerebral ischemia. An in vivo magnetic resonance spectroscopic analysis

Glutamate Excitoxicity Is the Key Molecular Mechanism Which Is Influenced by Body Temperature during the Acute Phase of Brain Stroke

Growth factors mediate reduction of infarct volume and functional recovery in cerebral ischemia through the increase of circulating mesenchymal stem cells

Guía de recomendaciones en la aplicación de modelos animales para el estudio del ictus

High blood glutamate oxaloacetate transaminase levels are associated with good functional outcome in acute ischemic stroke

Human recombinant glutamate oxaloacetate transaminase 1 (GOT1) supplemented with oxaloacetate induces a protective effect after cerebral ischemia

In Vivo Theranostics at the Peri-Infarct Region in Cerebral Ischemia

Influence of temperature on ischemic brain: Basic and clinical principles

Interleukin-10 facilitates the selection of patients for systemic thrombolysis

Liposomes and nanotechnology in drug development: focus on neurological targets

Los niveles de expresión de los receptores toll-like 2 y 4 en neutrófilos se asocian con el pronóstico de los pacientes con ictus isquémico.

Molecular profiling of the peri-infarct region dynamics in cerebral ischemia

MRI Stem Cell Tracking for Therapy in Experimental Cerebral Ischemia

Neuroprotection afforded by antagonists of endothelin-1 receptors in experimental stroke

Neuroprotection by glutamate oxaloacetate transaminase in ischemic stroke: an experimental study.

OXALOACETATE INDUCES A POTENTIATION OF THE PROTECTIVE EFFECTS OF GLUTAMATE OXALOACETATE TRANSAMINASE AFTER CEREBRAL ISCHEMIA

Oxaloacetate: A novel neuroprotective for acute ischemic stroke

Pre-stimulation of mesenchymal stem cells with growth factors increase their neurorepair effects in cerebral ischemia